They demonstrated a marked cell cycle arrest, induction of apoptosis and inhibition of S6 and Akt phosphorylation in vitro combining PI-103 (a PI3K inhibitor) with rapamycin, and a statistically significant reduction in tumor volume in a human melanoma xenograft model. Here, AKT1 is linked to melanoma.